🇺🇸 FDA
Patent

US 10023628

Cell line expressing single chain factor VIII polypeptides and uses thereof

granted A61KA61K35/00A61K38/00

Quick answer

US patent 10023628 (Cell line expressing single chain factor VIII polypeptides and uses thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVERATIV THERAPEUTICS INC.
Grant date
Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K35/00, A61K38/00